p110γ Search Results


93
Santa Cruz Biotechnology anti pi3k p110c
Fig. 7. CD36 promotes the recruitment of <t>p110c</t> to lipid rafts. A, B, The expression of p110c was determined by immunofluorescence staining along with the quantification in WT and Cd36-/- BMDMs (A), or NC and CD36 OE THP-1 cells (B) in the presence of TCM (n = 5). C, Representative histogram (left) and quantitative results of the MFI of p110c surface staining in BMDMs (n = 4). D, The expression of AKT and p110c in whole cell lysate (WCL), membrane (Mem), and cytoplasm (Cyto) in WT and Cd36-/- BMDMs was measured along with the quantification (n = 3). E, F, The expression of the lipid raft marker-Flotillin1 was determined by immunofluorescence staining along with the quantification in BMDMs (E) and THP-1 cells (F) (n = 5). G, Representative histogram (above) and quantitative results of the MFI of Flotillin1 surface staining in BMDMs (n = 4). H, The levels of p110c in the lipid rafts were detected in BMDMs and THP-1 cells along with the quantification (n = 3). Values for n represent biologically independent samples. Data are presented as mean ± SEM. *p < 0.05, ** p < 0.01, *** p < 0.001. Unpaired two-tailed t-test (A-H).
Anti Pi3k P110c, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti pi3k p110c/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
anti pi3k p110c - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

85
Santa Cruz Biotechnology pi3k p110γ subunit
PACAP potently increases sympathetic Akt phosphorylation. A , primary sympathetic neuronal cultures were withdrawn from NGF (as in ) and treated with different concentrations of PACAP for 2 h before extraction and Western blot analyses. As with ERK, PACAP potently increased Akt phosphorylation. B , for studies with signaling pathway inhibitors, NGF-deprived cultures were pretreated with the indicated inhibitors for 15 min before peptide addition for 2 h. <t>PI3K</t> inhibitor LY294002 (25 μ m ) blocked PACAP-mediated Akt phosphorylation. MEK and PKC inhibitors, PD98059 (25 μ m ), and bisindolylmaleimide I ( BimI , 15 μ m ) and the inactive LY294002 analog LY303511 (25 μ m ) had little or no effects. Application of the PKA inhibitor H89 (25 μ m ) consistently potentiated PACAP-stimulated Akt phosphorylation. Data are representative of four independent experiments.
Pi3k P110γ Subunit, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pi3k p110γ subunit/product/Santa Cruz Biotechnology
Average 85 stars, based on 1 article reviews
pi3k p110γ subunit - by Bioz Stars, 2026-02
85/100 stars
  Buy from Supplier

93
BPS Bioscience pi3kγ p110γ assay kit
Baicalein is a potential inhibitor of <t>PI3Kγ.</t> (A) pharmacological network of baicalein (molecular ID: mol002714) and melanoma targets generated with Cytoscape V3.8.1. The property of yellow nodes are the common targets of drug and disease. All protein targets are represented by their gene symbols. (B) , protein-protein interaction (PPI) network of drug and disease target analysis. (C,D) the mRNA expression and protein levels of PI3Kγ p110 in THP-1-derived M1 macrophages with or without baicalein treatment. (E) the molecular docking of baicalein on PI3Kγ. (F) the binding curve of baicalein to PI3Kγ was measured by SPR. (G) the inhibitory effect of baicalein on PI3Kγ. Data are presented as mean ± SD and are obtained from at least independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, for comparison with control group. BA = baicalein.
Pi3kγ P110γ Assay Kit, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pi3kγ p110γ assay kit/product/BPS Bioscience
Average 93 stars, based on 1 article reviews
pi3kγ p110γ assay kit - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

90
Knobbe Martens p110γ
Baicalein is a potential inhibitor of <t>PI3Kγ.</t> (A) pharmacological network of baicalein (molecular ID: mol002714) and melanoma targets generated with Cytoscape V3.8.1. The property of yellow nodes are the common targets of drug and disease. All protein targets are represented by their gene symbols. (B) , protein-protein interaction (PPI) network of drug and disease target analysis. (C,D) the mRNA expression and protein levels of PI3Kγ p110 in THP-1-derived M1 macrophages with or without baicalein treatment. (E) the molecular docking of baicalein on PI3Kγ. (F) the binding curve of baicalein to PI3Kγ was measured by SPR. (G) the inhibitory effect of baicalein on PI3Kγ. Data are presented as mean ± SD and are obtained from at least independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, for comparison with control group. BA = baicalein.
P110γ, supplied by Knobbe Martens, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p110γ/product/Knobbe Martens
Average 90 stars, based on 1 article reviews
p110γ - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Onyx Pharmaceuticals rabbit anti-p110γ
Baicalein is a potential inhibitor of <t>PI3Kγ.</t> (A) pharmacological network of baicalein (molecular ID: mol002714) and melanoma targets generated with Cytoscape V3.8.1. The property of yellow nodes are the common targets of drug and disease. All protein targets are represented by their gene symbols. (B) , protein-protein interaction (PPI) network of drug and disease target analysis. (C,D) the mRNA expression and protein levels of PI3Kγ p110 in THP-1-derived M1 macrophages with or without baicalein treatment. (E) the molecular docking of baicalein on PI3Kγ. (F) the binding curve of baicalein to PI3Kγ was measured by SPR. (G) the inhibitory effect of baicalein on PI3Kγ. Data are presented as mean ± SD and are obtained from at least independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, for comparison with control group. BA = baicalein.
Rabbit Anti P110γ, supplied by Onyx Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-p110γ/product/Onyx Pharmaceuticals
Average 90 stars, based on 1 article reviews
rabbit anti-p110γ - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
BioGenes GmbH mab(a) p110 γ antibody
Baicalein is a potential inhibitor of <t>PI3Kγ.</t> (A) pharmacological network of baicalein (molecular ID: mol002714) and melanoma targets generated with Cytoscape V3.8.1. The property of yellow nodes are the common targets of drug and disease. All protein targets are represented by their gene symbols. (B) , protein-protein interaction (PPI) network of drug and disease target analysis. (C,D) the mRNA expression and protein levels of PI3Kγ p110 in THP-1-derived M1 macrophages with or without baicalein treatment. (E) the molecular docking of baicalein on PI3Kγ. (F) the binding curve of baicalein to PI3Kγ was measured by SPR. (G) the inhibitory effect of baicalein on PI3Kγ. Data are presented as mean ± SD and are obtained from at least independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, for comparison with control group. BA = baicalein.
Mab(A) P110 γ Antibody, supplied by BioGenes GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mab(a) p110 γ antibody/product/BioGenes GmbH
Average 90 stars, based on 1 article reviews
mab(a) p110 γ antibody - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Walser GmbH p110γ
Baicalein is a potential inhibitor of <t>PI3Kγ.</t> (A) pharmacological network of baicalein (molecular ID: mol002714) and melanoma targets generated with Cytoscape V3.8.1. The property of yellow nodes are the common targets of drug and disease. All protein targets are represented by their gene symbols. (B) , protein-protein interaction (PPI) network of drug and disease target analysis. (C,D) the mRNA expression and protein levels of PI3Kγ p110 in THP-1-derived M1 macrophages with or without baicalein treatment. (E) the molecular docking of baicalein on PI3Kγ. (F) the binding curve of baicalein to PI3Kγ was measured by SPR. (G) the inhibitory effect of baicalein on PI3Kγ. Data are presented as mean ± SD and are obtained from at least independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, for comparison with control group. BA = baicalein.
P110γ, supplied by Walser GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p110γ/product/Walser GmbH
Average 90 stars, based on 1 article reviews
p110γ - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Hubner GmbH pi3k ko mice
Baicalein is a potential inhibitor of <t>PI3Kγ.</t> (A) pharmacological network of baicalein (molecular ID: mol002714) and melanoma targets generated with Cytoscape V3.8.1. The property of yellow nodes are the common targets of drug and disease. All protein targets are represented by their gene symbols. (B) , protein-protein interaction (PPI) network of drug and disease target analysis. (C,D) the mRNA expression and protein levels of PI3Kγ p110 in THP-1-derived M1 macrophages with or without baicalein treatment. (E) the molecular docking of baicalein on PI3Kγ. (F) the binding curve of baicalein to PI3Kγ was measured by SPR. (G) the inhibitory effect of baicalein on PI3Kγ. Data are presented as mean ± SD and are obtained from at least independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, for comparison with control group. BA = baicalein.
Pi3k Ko Mice, supplied by Hubner GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pi3k ko mice/product/Hubner GmbH
Average 90 stars, based on 1 article reviews
pi3k ko mice - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Serono p110γ reagents
Baicalein is a potential inhibitor of <t>PI3Kγ.</t> (A) pharmacological network of baicalein (molecular ID: mol002714) and melanoma targets generated with Cytoscape V3.8.1. The property of yellow nodes are the common targets of drug and disease. All protein targets are represented by their gene symbols. (B) , protein-protein interaction (PPI) network of drug and disease target analysis. (C,D) the mRNA expression and protein levels of PI3Kγ p110 in THP-1-derived M1 macrophages with or without baicalein treatment. (E) the molecular docking of baicalein on PI3Kγ. (F) the binding curve of baicalein to PI3Kγ was measured by SPR. (G) the inhibitory effect of baicalein on PI3Kγ. Data are presented as mean ± SD and are obtained from at least independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, for comparison with control group. BA = baicalein.
P110γ Reagents, supplied by Serono, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p110γ reagents/product/Serono
Average 90 stars, based on 1 article reviews
p110γ reagents - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Takeda kinase-dead mutant of class 1b p110γ
Baicalein is a potential inhibitor of <t>PI3Kγ.</t> (A) pharmacological network of baicalein (molecular ID: mol002714) and melanoma targets generated with Cytoscape V3.8.1. The property of yellow nodes are the common targets of drug and disease. All protein targets are represented by their gene symbols. (B) , protein-protein interaction (PPI) network of drug and disease target analysis. (C,D) the mRNA expression and protein levels of PI3Kγ p110 in THP-1-derived M1 macrophages with or without baicalein treatment. (E) the molecular docking of baicalein on PI3Kγ. (F) the binding curve of baicalein to PI3Kγ was measured by SPR. (G) the inhibitory effect of baicalein on PI3Kγ. Data are presented as mean ± SD and are obtained from at least independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, for comparison with control group. BA = baicalein.
Kinase Dead Mutant Of Class 1b P110γ, supplied by Takeda, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kinase-dead mutant of class 1b p110γ/product/Takeda
Average 90 stars, based on 1 article reviews
kinase-dead mutant of class 1b p110γ - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Upstate Biotechnology Inc anti-p110γ antibody
Baicalein is a potential inhibitor of <t>PI3Kγ.</t> (A) pharmacological network of baicalein (molecular ID: mol002714) and melanoma targets generated with Cytoscape V3.8.1. The property of yellow nodes are the common targets of drug and disease. All protein targets are represented by their gene symbols. (B) , protein-protein interaction (PPI) network of drug and disease target analysis. (C,D) the mRNA expression and protein levels of PI3Kγ p110 in THP-1-derived M1 macrophages with or without baicalein treatment. (E) the molecular docking of baicalein on PI3Kγ. (F) the binding curve of baicalein to PI3Kγ was measured by SPR. (G) the inhibitory effect of baicalein on PI3Kγ. Data are presented as mean ± SD and are obtained from at least independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, for comparison with control group. BA = baicalein.
Anti P110γ Antibody, supplied by Upstate Biotechnology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-p110γ antibody/product/Upstate Biotechnology Inc
Average 90 stars, based on 1 article reviews
anti-p110γ antibody - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
BioGenes GmbH mab(a)p110γ
Baicalein is a potential inhibitor of <t>PI3Kγ.</t> (A) pharmacological network of baicalein (molecular ID: mol002714) and melanoma targets generated with Cytoscape V3.8.1. The property of yellow nodes are the common targets of drug and disease. All protein targets are represented by their gene symbols. (B) , protein-protein interaction (PPI) network of drug and disease target analysis. (C,D) the mRNA expression and protein levels of PI3Kγ p110 in THP-1-derived M1 macrophages with or without baicalein treatment. (E) the molecular docking of baicalein on PI3Kγ. (F) the binding curve of baicalein to PI3Kγ was measured by SPR. (G) the inhibitory effect of baicalein on PI3Kγ. Data are presented as mean ± SD and are obtained from at least independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, for comparison with control group. BA = baicalein.
Mab(A)P110γ, supplied by BioGenes GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mab(a)p110γ/product/BioGenes GmbH
Average 90 stars, based on 1 article reviews
mab(a)p110γ - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Fig. 7. CD36 promotes the recruitment of p110c to lipid rafts. A, B, The expression of p110c was determined by immunofluorescence staining along with the quantification in WT and Cd36-/- BMDMs (A), or NC and CD36 OE THP-1 cells (B) in the presence of TCM (n = 5). C, Representative histogram (left) and quantitative results of the MFI of p110c surface staining in BMDMs (n = 4). D, The expression of AKT and p110c in whole cell lysate (WCL), membrane (Mem), and cytoplasm (Cyto) in WT and Cd36-/- BMDMs was measured along with the quantification (n = 3). E, F, The expression of the lipid raft marker-Flotillin1 was determined by immunofluorescence staining along with the quantification in BMDMs (E) and THP-1 cells (F) (n = 5). G, Representative histogram (above) and quantitative results of the MFI of Flotillin1 surface staining in BMDMs (n = 4). H, The levels of p110c in the lipid rafts were detected in BMDMs and THP-1 cells along with the quantification (n = 3). Values for n represent biologically independent samples. Data are presented as mean ± SEM. *p < 0.05, ** p < 0.01, *** p < 0.001. Unpaired two-tailed t-test (A-H).

Journal: Journal of advanced research

Article Title: The fatty acid receptor CD36 promotes macrophage infiltration via p110γ signaling to stimulate metastasis.

doi: 10.1016/j.jare.2024.10.006

Figure Lengend Snippet: Fig. 7. CD36 promotes the recruitment of p110c to lipid rafts. A, B, The expression of p110c was determined by immunofluorescence staining along with the quantification in WT and Cd36-/- BMDMs (A), or NC and CD36 OE THP-1 cells (B) in the presence of TCM (n = 5). C, Representative histogram (left) and quantitative results of the MFI of p110c surface staining in BMDMs (n = 4). D, The expression of AKT and p110c in whole cell lysate (WCL), membrane (Mem), and cytoplasm (Cyto) in WT and Cd36-/- BMDMs was measured along with the quantification (n = 3). E, F, The expression of the lipid raft marker-Flotillin1 was determined by immunofluorescence staining along with the quantification in BMDMs (E) and THP-1 cells (F) (n = 5). G, Representative histogram (above) and quantitative results of the MFI of Flotillin1 surface staining in BMDMs (n = 4). H, The levels of p110c in the lipid rafts were detected in BMDMs and THP-1 cells along with the quantification (n = 3). Values for n represent biologically independent samples. Data are presented as mean ± SEM. *p < 0.05, ** p < 0.01, *** p < 0.001. Unpaired two-tailed t-test (A-H).

Article Snippet: The following primary antibodies were used: antiF4/80 (Abcam, Cambridge, UK #ab6640, 1:200), anti-PI3K p110c (1:500, #sc-166365, Santa Cruz Biotechnology), anti-Flotillin1 (1:500, #15571-1-AP, Proteintech, Wuhan, China).

Techniques: Expressing, Staining, Membrane, Marker, Two Tailed Test

Fig. 8. CD36-mediated lipid reprogramming induces the activation of lipid raft-associated p110c.A, B, Representative histogram (right) and quantitative results of the MFI of Flotillin1 (A) or p110c (B) surface staining in NC and CD36 OE THP-1 cells treated with MbCD (n = 4). C, The protein expression of P-AKT and AKT were determined in THP-1 cells treated with or without MbCD along with the quantification. D, E, Migration (D) or adhesion (E) assay was performed in THP-1 cells treated with or without MbCD (n = 5). F, The volcano diagram showed the difference of sphingolipids between WT and Cd36-/- BMDMs (n = 5). G, Enriched different lipid classes between WT and Cd36-/- BMDMs. H, I, Migration (H) or adhesion (I) assay was performed in BMDMs treated with or without ceramide (n = 3). J, K, The expression of Flotillin1 (J) and p110c (K) on the cell membrane was observed by confocal microscopy in WT and Cd36-/- BMDMs treated with or without ceramide (n = 3–4). Values for n represent biologically independent samples. Data are presented as mean ± SEM. *p < 0.05, ** p < 0.01, and *** p < 0.001 vs the control group; # p < 0.01, ## p < 0.01, and ### p < 0.001 vs the WT group. ANOVA (A-K).

Journal: Journal of advanced research

Article Title: The fatty acid receptor CD36 promotes macrophage infiltration via p110γ signaling to stimulate metastasis.

doi: 10.1016/j.jare.2024.10.006

Figure Lengend Snippet: Fig. 8. CD36-mediated lipid reprogramming induces the activation of lipid raft-associated p110c.A, B, Representative histogram (right) and quantitative results of the MFI of Flotillin1 (A) or p110c (B) surface staining in NC and CD36 OE THP-1 cells treated with MbCD (n = 4). C, The protein expression of P-AKT and AKT were determined in THP-1 cells treated with or without MbCD along with the quantification. D, E, Migration (D) or adhesion (E) assay was performed in THP-1 cells treated with or without MbCD (n = 5). F, The volcano diagram showed the difference of sphingolipids between WT and Cd36-/- BMDMs (n = 5). G, Enriched different lipid classes between WT and Cd36-/- BMDMs. H, I, Migration (H) or adhesion (I) assay was performed in BMDMs treated with or without ceramide (n = 3). J, K, The expression of Flotillin1 (J) and p110c (K) on the cell membrane was observed by confocal microscopy in WT and Cd36-/- BMDMs treated with or without ceramide (n = 3–4). Values for n represent biologically independent samples. Data are presented as mean ± SEM. *p < 0.05, ** p < 0.01, and *** p < 0.001 vs the control group; # p < 0.01, ## p < 0.01, and ### p < 0.001 vs the WT group. ANOVA (A-K).

Article Snippet: The following primary antibodies were used: antiF4/80 (Abcam, Cambridge, UK #ab6640, 1:200), anti-PI3K p110c (1:500, #sc-166365, Santa Cruz Biotechnology), anti-Flotillin1 (1:500, #15571-1-AP, Proteintech, Wuhan, China).

Techniques: Activation Assay, Staining, Expressing, Migration, Membrane, Confocal Microscopy, Control

PACAP potently increases sympathetic Akt phosphorylation. A , primary sympathetic neuronal cultures were withdrawn from NGF (as in ) and treated with different concentrations of PACAP for 2 h before extraction and Western blot analyses. As with ERK, PACAP potently increased Akt phosphorylation. B , for studies with signaling pathway inhibitors, NGF-deprived cultures were pretreated with the indicated inhibitors for 15 min before peptide addition for 2 h. PI3K inhibitor LY294002 (25 μ m ) blocked PACAP-mediated Akt phosphorylation. MEK and PKC inhibitors, PD98059 (25 μ m ), and bisindolylmaleimide I ( BimI , 15 μ m ) and the inactive LY294002 analog LY303511 (25 μ m ) had little or no effects. Application of the PKA inhibitor H89 (25 μ m ) consistently potentiated PACAP-stimulated Akt phosphorylation. Data are representative of four independent experiments.

Journal: The Journal of Biological Chemistry

Article Title: Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)/PAC 1 HOP1 Receptor Activation Coordinates Multiple Neurotrophic Signaling Pathways

doi: 10.1074/jbc.M109.043117

Figure Lengend Snippet: PACAP potently increases sympathetic Akt phosphorylation. A , primary sympathetic neuronal cultures were withdrawn from NGF (as in ) and treated with different concentrations of PACAP for 2 h before extraction and Western blot analyses. As with ERK, PACAP potently increased Akt phosphorylation. B , for studies with signaling pathway inhibitors, NGF-deprived cultures were pretreated with the indicated inhibitors for 15 min before peptide addition for 2 h. PI3K inhibitor LY294002 (25 μ m ) blocked PACAP-mediated Akt phosphorylation. MEK and PKC inhibitors, PD98059 (25 μ m ), and bisindolylmaleimide I ( BimI , 15 μ m ) and the inactive LY294002 analog LY303511 (25 μ m ) had little or no effects. Application of the PKA inhibitor H89 (25 μ m ) consistently potentiated PACAP-stimulated Akt phosphorylation. Data are representative of four independent experiments.

Article Snippet: For knockdown studies, 70% confluent cells in 24-well plates were transfected with siRNAs to mouse Gα q or PI3K p110γ subunit (Santa Cruz Biotechnology) using Lipofectamine 2000 (10 pmol of siRNA/2 μl of transfection reagent; Invitrogen).

Techniques: Phospho-proteomics, Extraction, Western Blot

Inhibition of Gα q and PI3Kγ signaling attenuates PACAP-stimulated Akt activation. A , sympathetic neuronal cultures were acutely withdrawn from NGF for 4 h to attenuate cellular Akt phosphorylation levels, then pretreated with 10 μ m AS252424 (15 min) to selectively inhibit PI3Kγ activity before 100 n m PACAP27 addition for 4 h. AS252424 blocked PACAP/PAC 1 receptor-stimulated Akt activation but did not attenuate NGF/TrkA-stimulated Akt phosphorylation (not shown). Identical results were obtained with PI3Kγ-selective inhibitor AS605240. B , treatment of stable AtT-20/PAC 1 HOP1 cultures with 100 n m PACAP27 for 4 h stimulated Akt phosphorylation; as in panel A with primary sympathetic neurons, the response was blocked upon inhibition with PI3Kγ-selective AS252424 (10 μ m ) treatment. AtT-20/PAC 1 HOP1 cultures were transfected at 70% confluency with mouse siRNA oligonucleotides to affect Gα q ( C ) or PI3Kγ ( D ) knockdown. After 48 h, the cultures were treated with 100 n m PACAP27 for 4 h. PACAP-stimulated Akt phosphorylation was attenuated when Gα q or PI3Kγ expression was diminished. Culture total Akt levels demonstrate loading equivalency across all samples. Representative data are from 2–4 experiments.

Journal: The Journal of Biological Chemistry

Article Title: Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)/PAC 1 HOP1 Receptor Activation Coordinates Multiple Neurotrophic Signaling Pathways

doi: 10.1074/jbc.M109.043117

Figure Lengend Snippet: Inhibition of Gα q and PI3Kγ signaling attenuates PACAP-stimulated Akt activation. A , sympathetic neuronal cultures were acutely withdrawn from NGF for 4 h to attenuate cellular Akt phosphorylation levels, then pretreated with 10 μ m AS252424 (15 min) to selectively inhibit PI3Kγ activity before 100 n m PACAP27 addition for 4 h. AS252424 blocked PACAP/PAC 1 receptor-stimulated Akt activation but did not attenuate NGF/TrkA-stimulated Akt phosphorylation (not shown). Identical results were obtained with PI3Kγ-selective inhibitor AS605240. B , treatment of stable AtT-20/PAC 1 HOP1 cultures with 100 n m PACAP27 for 4 h stimulated Akt phosphorylation; as in panel A with primary sympathetic neurons, the response was blocked upon inhibition with PI3Kγ-selective AS252424 (10 μ m ) treatment. AtT-20/PAC 1 HOP1 cultures were transfected at 70% confluency with mouse siRNA oligonucleotides to affect Gα q ( C ) or PI3Kγ ( D ) knockdown. After 48 h, the cultures were treated with 100 n m PACAP27 for 4 h. PACAP-stimulated Akt phosphorylation was attenuated when Gα q or PI3Kγ expression was diminished. Culture total Akt levels demonstrate loading equivalency across all samples. Representative data are from 2–4 experiments.

Article Snippet: For knockdown studies, 70% confluent cells in 24-well plates were transfected with siRNAs to mouse Gα q or PI3K p110γ subunit (Santa Cruz Biotechnology) using Lipofectamine 2000 (10 pmol of siRNA/2 μl of transfection reagent; Invitrogen).

Techniques: Inhibition, Activation Assay, Phospho-proteomics, Activity Assay, Transfection, Knockdown, Expressing

PACAP-mediated Akt signaling is neuroprotective in sympathetic neuronal cultures. A , shown is an experimental schematic for PACAP-mediated sympathetic neuronal survival. After NGF withdrawal (0 h) from immature sympathetic neuronal cultures, there is a 12–15-h survival window delaying neuronal commitment to apoptosis. If NGF is returned to the culture within the survival window ( a ), the cultures continue to live ( black solid arrows ) and do not undergo apoptosis programs. But if NGF is returned to the cultures outside of window parameters ( b ), the neurons are committed to apoptosis, and subsequent NGF addition is unable to affect rescue ( red broken arrows ). The addition of PACAP in place of NGF during the survival window extends the survival period ( c ) such that a much delayed addition of NGF ( blue bar ) can fully protect the neurons ( d ). Accordingly, the addition of signaling inhibitors ( hatched bars , e and f ) with PACAP during the window period will block the extended survival period and can be diagnostic of PACAP neurotrophic pathways. B , in this paradigm using the MTS survival assay ( lanes a–f correspond to those in panel A ), NGF replacement outside of the survival window did not offer neuroprotection when survival was assessed 48 h later ( b ). PACAP alone offered 50% protection ( c ) in NGF-deprived cultures, whereas the sequential addition of PACAP + NGF as described above was fully protective ( d ). Between ERK and Akt pathways, only LY294002 blocked the abilities for PACAP to promote neuronal survival in this experimental paradigm ( e ). As the MEK inhibitor PD98059 had no apparent effects ( f ), these results suggested that PI3K/Akt signaling may be more immediate in mediating PACAP survival signaling. Data represent the mean of 5–6 culture replicates ± S.E.; *, significantly different from control; +, different from PACAP-rescued cultures at p < 0.05.

Journal: The Journal of Biological Chemistry

Article Title: Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)/PAC 1 HOP1 Receptor Activation Coordinates Multiple Neurotrophic Signaling Pathways

doi: 10.1074/jbc.M109.043117

Figure Lengend Snippet: PACAP-mediated Akt signaling is neuroprotective in sympathetic neuronal cultures. A , shown is an experimental schematic for PACAP-mediated sympathetic neuronal survival. After NGF withdrawal (0 h) from immature sympathetic neuronal cultures, there is a 12–15-h survival window delaying neuronal commitment to apoptosis. If NGF is returned to the culture within the survival window ( a ), the cultures continue to live ( black solid arrows ) and do not undergo apoptosis programs. But if NGF is returned to the cultures outside of window parameters ( b ), the neurons are committed to apoptosis, and subsequent NGF addition is unable to affect rescue ( red broken arrows ). The addition of PACAP in place of NGF during the survival window extends the survival period ( c ) such that a much delayed addition of NGF ( blue bar ) can fully protect the neurons ( d ). Accordingly, the addition of signaling inhibitors ( hatched bars , e and f ) with PACAP during the window period will block the extended survival period and can be diagnostic of PACAP neurotrophic pathways. B , in this paradigm using the MTS survival assay ( lanes a–f correspond to those in panel A ), NGF replacement outside of the survival window did not offer neuroprotection when survival was assessed 48 h later ( b ). PACAP alone offered 50% protection ( c ) in NGF-deprived cultures, whereas the sequential addition of PACAP + NGF as described above was fully protective ( d ). Between ERK and Akt pathways, only LY294002 blocked the abilities for PACAP to promote neuronal survival in this experimental paradigm ( e ). As the MEK inhibitor PD98059 had no apparent effects ( f ), these results suggested that PI3K/Akt signaling may be more immediate in mediating PACAP survival signaling. Data represent the mean of 5–6 culture replicates ± S.E.; *, significantly different from control; +, different from PACAP-rescued cultures at p < 0.05.

Article Snippet: For knockdown studies, 70% confluent cells in 24-well plates were transfected with siRNAs to mouse Gα q or PI3K p110γ subunit (Santa Cruz Biotechnology) using Lipofectamine 2000 (10 pmol of siRNA/2 μl of transfection reagent; Invitrogen).

Techniques: Blocking Assay, Diagnostic Assay, Clonogenic Cell Survival Assay, Control

Schematic of coordinate PACAP receptor signaling for sympathetic neuronal survival. The ability for the PAC 1 receptor to engage Gα s /Gα q signaling pathways represents a multifaceted but coordinate means for neurotrophic signaling. PAC 1 receptor Gα s signaling in sympathetic neurons can stimulate cAMP mechanisms to promote sustained ERK activation. In addition to rapid PAC 1 receptor-mediated Gα q activation of phospholipase C /PKC pathways, the internalization of PAC 1 receptors through clathrin-coated vesicles may facilitate scaffold assembly to engage PI3kγ/Akt signaling for survival mechanisms. Whether ERK, Akt, or other PAC 1 receptor-stimulated mechanisms attenuate JNK/p38 MAPK activation after NGF-deprivation remains to be elucidated. PDK , phosphoinositide-dependent protein kinase; AC , adenylyl cyclase.

Journal: The Journal of Biological Chemistry

Article Title: Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)/PAC 1 HOP1 Receptor Activation Coordinates Multiple Neurotrophic Signaling Pathways

doi: 10.1074/jbc.M109.043117

Figure Lengend Snippet: Schematic of coordinate PACAP receptor signaling for sympathetic neuronal survival. The ability for the PAC 1 receptor to engage Gα s /Gα q signaling pathways represents a multifaceted but coordinate means for neurotrophic signaling. PAC 1 receptor Gα s signaling in sympathetic neurons can stimulate cAMP mechanisms to promote sustained ERK activation. In addition to rapid PAC 1 receptor-mediated Gα q activation of phospholipase C /PKC pathways, the internalization of PAC 1 receptors through clathrin-coated vesicles may facilitate scaffold assembly to engage PI3kγ/Akt signaling for survival mechanisms. Whether ERK, Akt, or other PAC 1 receptor-stimulated mechanisms attenuate JNK/p38 MAPK activation after NGF-deprivation remains to be elucidated. PDK , phosphoinositide-dependent protein kinase; AC , adenylyl cyclase.

Article Snippet: For knockdown studies, 70% confluent cells in 24-well plates were transfected with siRNAs to mouse Gα q or PI3K p110γ subunit (Santa Cruz Biotechnology) using Lipofectamine 2000 (10 pmol of siRNA/2 μl of transfection reagent; Invitrogen).

Techniques: Protein-Protein interactions, Activation Assay

Baicalein is a potential inhibitor of PI3Kγ. (A) pharmacological network of baicalein (molecular ID: mol002714) and melanoma targets generated with Cytoscape V3.8.1. The property of yellow nodes are the common targets of drug and disease. All protein targets are represented by their gene symbols. (B) , protein-protein interaction (PPI) network of drug and disease target analysis. (C,D) the mRNA expression and protein levels of PI3Kγ p110 in THP-1-derived M1 macrophages with or without baicalein treatment. (E) the molecular docking of baicalein on PI3Kγ. (F) the binding curve of baicalein to PI3Kγ was measured by SPR. (G) the inhibitory effect of baicalein on PI3Kγ. Data are presented as mean ± SD and are obtained from at least independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, for comparison with control group. BA = baicalein.

Journal: Frontiers in Pharmacology

Article Title: Baicalein Potentiated M1 Macrophage Polarization in Cancer Through Targeting PI3Kγ/ NF-κB Signaling

doi: 10.3389/fphar.2021.743837

Figure Lengend Snippet: Baicalein is a potential inhibitor of PI3Kγ. (A) pharmacological network of baicalein (molecular ID: mol002714) and melanoma targets generated with Cytoscape V3.8.1. The property of yellow nodes are the common targets of drug and disease. All protein targets are represented by their gene symbols. (B) , protein-protein interaction (PPI) network of drug and disease target analysis. (C,D) the mRNA expression and protein levels of PI3Kγ p110 in THP-1-derived M1 macrophages with or without baicalein treatment. (E) the molecular docking of baicalein on PI3Kγ. (F) the binding curve of baicalein to PI3Kγ was measured by SPR. (G) the inhibitory effect of baicalein on PI3Kγ. Data are presented as mean ± SD and are obtained from at least independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, for comparison with control group. BA = baicalein.

Article Snippet: For the measurement of the kinase activity of PI3Kγ, ADP-Glo kinase assay kit (Promega, Madison, WI, United States, Cat#V910) and PI3Kγ (p110γ) assay kit (BPS Bioscience, San Diego, CA, Cat#79803) were used.

Techniques: Generated, Expressing, Derivative Assay, Binding Assay